Endocannabinoid receptor blockade reduces alanine aminotransferase in polycystic ovary syndrome independent of weight loss

BACKGROUND: Evidence suggests that endocannabinoid system activation through the cannabinoid receptor 1 (CB1) is associated with enhanced liver injury, and CB1 antagonism may be beneficial. The aim of this study was to determine the impact of rimonabant (CB1 antagonist) on alanine aminotransferase (...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:BMC Endocr Disord
Main Authors: Dawson, Alison J., Kilpatrick, Eric S., Coady, Anne-Marie, Elshewehy, Abeer M. M., Dakroury, Youssra, Ahmed, Lina, Atkin, Stephen L., Sathyapalan, Thozhukat
Formato: Artigo
Idioma:Inglês
Publicado em: BioMed Central 2017
Assuntos:
Research Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5512818/
https://ncbi.nlm.nih.gov/pubmed/28705172
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12902-017-0194-2
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados